Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria, Falciparum | 16 | 2023 | 81 | 8.260 |
Why?
|
Plasmodium falciparum | 15 | 2023 | 121 | 6.320 |
Why?
|
Antibodies, Protozoan | 15 | 2023 | 77 | 6.270 |
Why?
|
Antigens, Protozoan | 14 | 2023 | 71 | 6.170 |
Why?
|
Campylobacter jejuni | 10 | 2009 | 21 | 2.540 |
Why?
|
Plasmids | 12 | 2009 | 233 | 2.530 |
Why?
|
Antibody Affinity | 4 | 2021 | 25 | 2.310 |
Why?
|
Conjugation, Genetic | 11 | 2008 | 14 | 2.260 |
Why?
|
Helicobacter pylori | 12 | 2010 | 105 | 2.090 |
Why?
|
Drug Resistance, Bacterial | 11 | 2009 | 78 | 1.940 |
Why?
|
Escherichia coli Proteins | 8 | 2010 | 119 | 1.710 |
Why?
|
Pregnancy Complications, Parasitic | 3 | 2021 | 12 | 1.620 |
Why?
|
Escherichia coli | 13 | 2010 | 436 | 1.340 |
Why?
|
Tetracycline Resistance | 5 | 2007 | 5 | 1.300 |
Why?
|
Fucosyltransferases | 5 | 2006 | 7 | 1.270 |
Why?
|
Immunoglobulin G | 6 | 2023 | 232 | 1.250 |
Why?
|
Cameroon | 10 | 2021 | 35 | 1.220 |
Why?
|
Merozoites | 3 | 2021 | 4 | 1.180 |
Why?
|
Bacterial Proteins | 12 | 2008 | 520 | 1.170 |
Why?
|
Parasitemia | 3 | 2018 | 13 | 1.160 |
Why?
|
Placenta | 4 | 2023 | 91 | 1.140 |
Why?
|
Membrane Proteins | 6 | 2008 | 486 | 1.080 |
Why?
|
R Factors | 4 | 2005 | 4 | 1.070 |
Why?
|
Premature Birth | 2 | 2023 | 71 | 1.010 |
Why?
|
Pregnancy | 9 | 2023 | 1503 | 1.000 |
Why?
|
Infant | 8 | 2023 | 1014 | 0.960 |
Why?
|
Anti-Bacterial Agents | 5 | 2007 | 355 | 0.950 |
Why?
|
Merozoite Surface Protein 1 | 4 | 2022 | 34 | 0.900 |
Why?
|
Immunoglobulin M | 4 | 2022 | 81 | 0.880 |
Why?
|
Macrolides | 3 | 2007 | 11 | 0.870 |
Why?
|
Carrier Proteins | 6 | 2008 | 287 | 0.850 |
Why?
|
Malaria | 1 | 2022 | 68 | 0.850 |
Why?
|
Campylobacter coli | 3 | 2006 | 3 | 0.850 |
Why?
|
Pregnancy Outcome | 2 | 2021 | 90 | 0.830 |
Why?
|
DNA, Bacterial | 7 | 2007 | 184 | 0.790 |
Why?
|
Protozoan Proteins | 3 | 2018 | 170 | 0.750 |
Why?
|
Campylobacter Infections | 4 | 2006 | 8 | 0.690 |
Why?
|
Humans | 34 | 2023 | 34853 | 0.680 |
Why?
|
Infant, Newborn | 5 | 2023 | 871 | 0.660 |
Why?
|
Disease Susceptibility | 1 | 2018 | 92 | 0.620 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 63 | 0.610 |
Why?
|
Erythrocytes | 1 | 2017 | 107 | 0.600 |
Why?
|
Endemic Diseases | 1 | 2017 | 22 | 0.600 |
Why?
|
Young Adult | 10 | 2021 | 4012 | 0.590 |
Why?
|
Female | 15 | 2023 | 19873 | 0.570 |
Why?
|
Sulfadoxine | 1 | 2015 | 6 | 0.560 |
Why?
|
Pyrimethamine | 1 | 2015 | 10 | 0.560 |
Why?
|
Antimalarials | 1 | 2015 | 48 | 0.540 |
Why?
|
Monocytes | 1 | 2017 | 258 | 0.530 |
Why?
|
Temperature | 6 | 2017 | 275 | 0.520 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2005 | 165 | 0.520 |
Why?
|
Adult | 12 | 2022 | 11034 | 0.510 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2015 | 99 | 0.500 |
Why?
|
Tellurium | 3 | 2003 | 5 | 0.460 |
Why?
|
Molecular Sequence Data | 11 | 2005 | 1490 | 0.460 |
Why?
|
Mutation | 6 | 2010 | 1023 | 0.460 |
Why?
|
Adolescent | 9 | 2021 | 5035 | 0.450 |
Why?
|
Child, Preschool | 6 | 2021 | 1318 | 0.440 |
Why?
|
Erythromycin | 3 | 2007 | 14 | 0.430 |
Why?
|
Gene Transfer, Horizontal | 3 | 2009 | 24 | 0.430 |
Why?
|
Microbial Sensitivity Tests | 7 | 2007 | 203 | 0.420 |
Why?
|
Bacteria | 2 | 2006 | 245 | 0.420 |
Why?
|
Base Sequence | 7 | 2007 | 932 | 0.370 |
Why?
|
Polymerase Chain Reaction | 5 | 2019 | 430 | 0.360 |
Why?
|
Chorionic Gonadotropin | 1 | 2009 | 13 | 0.360 |
Why?
|
Epitopes | 1 | 2010 | 145 | 0.360 |
Why?
|
Immunoassay | 2 | 2020 | 57 | 0.350 |
Why?
|
Salmonella typhi | 1 | 2009 | 33 | 0.350 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2009 | 15 | 0.340 |
Why?
|
Transcription, Genetic | 3 | 2008 | 550 | 0.340 |
Why?
|
Child | 6 | 2021 | 2875 | 0.340 |
Why?
|
Toll-Like Receptor 2 | 1 | 2009 | 25 | 0.340 |
Why?
|
Intestines | 1 | 2009 | 63 | 0.340 |
Why?
|
Diagnostic Tests, Routine | 2 | 2019 | 47 | 0.320 |
Why?
|
Ribosomes | 3 | 2005 | 27 | 0.320 |
Why?
|
Interleukin-6 | 1 | 2009 | 140 | 0.320 |
Why?
|
Cell Membrane | 2 | 2008 | 360 | 0.320 |
Why?
|
Middle Aged | 8 | 2021 | 9642 | 0.320 |
Why?
|
Male | 10 | 2021 | 18870 | 0.310 |
Why?
|
Aged, 80 and over | 4 | 2021 | 2333 | 0.300 |
Why?
|
Fucose | 1 | 2006 | 4 | 0.300 |
Why?
|
Carbohydrate Metabolism | 1 | 2006 | 20 | 0.300 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2007 | 50 | 0.290 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2007 | 82 | 0.290 |
Why?
|
Liver Abscess | 1 | 2006 | 3 | 0.290 |
Why?
|
Epithelial Cells | 2 | 2010 | 366 | 0.290 |
Why?
|
Campylobacter | 1 | 2006 | 3 | 0.290 |
Why?
|
Poultry | 1 | 2006 | 7 | 0.280 |
Why?
|
Cloning, Molecular | 5 | 2004 | 310 | 0.270 |
Why?
|
Catalytic Domain | 1 | 2006 | 97 | 0.270 |
Why?
|
Subcellular Fractions | 1 | 2005 | 72 | 0.270 |
Why?
|
Tetracyclines | 1 | 2005 | 2 | 0.270 |
Why?
|
Plants | 1 | 2006 | 94 | 0.270 |
Why?
|
Tyrosine | 1 | 2005 | 109 | 0.260 |
Why?
|
Aged | 6 | 2021 | 6448 | 0.260 |
Why?
|
DNA Primers | 4 | 2007 | 269 | 0.260 |
Why?
|
Helicobacter Infections | 2 | 2005 | 74 | 0.260 |
Why?
|
Serratia marcescens | 1 | 2004 | 2 | 0.260 |
Why?
|
Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2004 | 3 | 0.260 |
Why?
|
Diarrhea | 1 | 2005 | 84 | 0.260 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 8 | 0.260 |
Why?
|
Mutagenesis, Site-Directed | 4 | 2005 | 168 | 0.250 |
Why?
|
Molecular Biology | 1 | 2004 | 44 | 0.250 |
Why?
|
Virulence Factors | 1 | 2005 | 113 | 0.250 |
Why?
|
Kanamycin Resistance | 1 | 2004 | 1 | 0.250 |
Why?
|
Nucleotides | 1 | 2004 | 33 | 0.250 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 445 | 0.240 |
Why?
|
Protein Structure, Tertiary | 3 | 2015 | 383 | 0.240 |
Why?
|
Recombinant Fusion Proteins | 4 | 2008 | 286 | 0.240 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2022 | 11 | 0.230 |
Why?
|
Antibody Formation | 1 | 2022 | 73 | 0.220 |
Why?
|
Adenosine Triphosphatases | 1 | 2003 | 78 | 0.220 |
Why?
|
Flow Cytometry | 2 | 2017 | 392 | 0.220 |
Why?
|
Escherichia coli O157 | 1 | 2002 | 17 | 0.220 |
Why?
|
Microscopy | 2 | 2019 | 32 | 0.210 |
Why?
|
Operon | 3 | 2008 | 43 | 0.210 |
Why?
|
Amino Acid Sequence | 4 | 2005 | 1124 | 0.200 |
Why?
|
Two-Hybrid System Techniques | 3 | 2007 | 49 | 0.200 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 40 | 0.200 |
Why?
|
Cities | 1 | 2021 | 61 | 0.190 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2006 | 249 | 0.190 |
Why?
|
Substrate Specificity | 3 | 2006 | 186 | 0.190 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2005 | 145 | 0.180 |
Why?
|
Sulfhydryl Compounds | 1 | 1999 | 46 | 0.180 |
Why?
|
Blood | 1 | 2019 | 32 | 0.170 |
Why?
|
Antigens, Bacterial | 1 | 1999 | 129 | 0.170 |
Why?
|
Luminescent Proteins | 3 | 2004 | 74 | 0.170 |
Why?
|
Transformation, Bacterial | 3 | 2005 | 11 | 0.170 |
Why?
|
Infant, Low Birth Weight | 1 | 2018 | 37 | 0.170 |
Why?
|
Green Fluorescent Proteins | 3 | 2004 | 200 | 0.160 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2008 | 195 | 0.160 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2018 | 67 | 0.160 |
Why?
|
Sequence Analysis, DNA | 4 | 2003 | 455 | 0.160 |
Why?
|
Microspheres | 1 | 2017 | 45 | 0.160 |
Why?
|
Reproducibility of Results | 2 | 2017 | 901 | 0.160 |
Why?
|
Phagocytosis | 1 | 2017 | 64 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 185 | 0.150 |
Why?
|
Recombinant Proteins | 2 | 2010 | 485 | 0.150 |
Why?
|
RNA, Ribosomal, 23S | 2 | 2007 | 4 | 0.150 |
Why?
|
Saliva | 1 | 2017 | 97 | 0.150 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 423 | 0.150 |
Why?
|
Lipopolysaccharides | 2 | 2010 | 200 | 0.140 |
Why?
|
Protein Conformation | 3 | 2008 | 350 | 0.140 |
Why?
|
Bacterial Typing Techniques | 2 | 2006 | 34 | 0.140 |
Why?
|
Insecticide-Treated Bednets | 1 | 2015 | 5 | 0.140 |
Why?
|
Immunoprecipitation | 2 | 2007 | 126 | 0.140 |
Why?
|
Placenta Diseases | 1 | 2015 | 5 | 0.140 |
Why?
|
Parity | 1 | 2015 | 46 | 0.140 |
Why?
|
Drug Combinations | 1 | 2015 | 89 | 0.140 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 145 | 0.140 |
Why?
|
Open Reading Frames | 2 | 2008 | 73 | 0.140 |
Why?
|
Genotype | 2 | 2010 | 641 | 0.130 |
Why?
|
Cell Line | 3 | 2010 | 1289 | 0.130 |
Why?
|
Animals | 7 | 2009 | 14307 | 0.130 |
Why?
|
Amino Acid Substitution | 2 | 2005 | 122 | 0.130 |
Why?
|
Biological Transport | 2 | 2007 | 175 | 0.130 |
Why?
|
Immunoblotting | 2 | 2006 | 170 | 0.120 |
Why?
|
Virulence | 2 | 2005 | 221 | 0.120 |
Why?
|
Sequence Alignment | 2 | 2004 | 257 | 0.110 |
Why?
|
Kinetics | 2 | 2006 | 650 | 0.110 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 2561 | 0.110 |
Why?
|
Genetic Complementation Test | 2 | 2003 | 56 | 0.110 |
Why?
|
Case-Control Studies | 1 | 2015 | 1056 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 605 | 0.100 |
Why?
|
Ligases | 1 | 2010 | 6 | 0.090 |
Why?
|
Glycosyltransferases | 1 | 2010 | 7 | 0.090 |
Why?
|
Papua New Guinea | 1 | 2010 | 20 | 0.090 |
Why?
|
Colombia | 1 | 2010 | 19 | 0.090 |
Why?
|
Retrospective Studies | 1 | 2015 | 1961 | 0.090 |
Why?
|
Cross Reactions | 1 | 2010 | 83 | 0.090 |
Why?
|
Gene Frequency | 1 | 2010 | 155 | 0.090 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2009 | 4 | 0.090 |
Why?
|
Coculture Techniques | 1 | 2009 | 96 | 0.090 |
Why?
|
Caco-2 Cells | 1 | 2009 | 48 | 0.090 |
Why?
|
Alleles | 1 | 2010 | 284 | 0.090 |
Why?
|
Peptide Elongation Factor G | 1 | 2008 | 1 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2010 | 249 | 0.080 |
Why?
|
Cosmids | 1 | 2008 | 2 | 0.080 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2008 | 17 | 0.080 |
Why?
|
Gastric Mucosa | 2 | 2010 | 50 | 0.080 |
Why?
|
Clarithromycin | 1 | 2007 | 8 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2009 | 528 | 0.080 |
Why?
|
Dipeptides | 1 | 2007 | 29 | 0.080 |
Why?
|
Guanosine Triphosphate | 1 | 2007 | 15 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2008 | 123 | 0.080 |
Why?
|
Culture Media | 1 | 2007 | 84 | 0.080 |
Why?
|
Circular Dichroism | 1 | 2007 | 60 | 0.080 |
Why?
|
Scattering, Radiation | 1 | 2007 | 45 | 0.080 |
Why?
|
Hydrolysis | 1 | 2007 | 86 | 0.080 |
Why?
|
Chromosomes, Bacterial | 1 | 2007 | 20 | 0.080 |
Why?
|
United States | 1 | 2017 | 3894 | 0.080 |
Why?
|
Solubility | 1 | 2007 | 115 | 0.080 |
Why?
|
Protein Transport | 1 | 2008 | 286 | 0.070 |
Why?
|
Light | 1 | 2007 | 180 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2007 | 140 | 0.070 |
Why?
|
Microbial Viability | 1 | 2006 | 35 | 0.070 |
Why?
|
MutS DNA Mismatch-Binding Protein | 1 | 2005 | 1 | 0.070 |
Why?
|
Oligosaccharides | 1 | 2006 | 24 | 0.070 |
Why?
|
Species Specificity | 1 | 2006 | 233 | 0.070 |
Why?
|
Point Mutation | 1 | 2005 | 88 | 0.070 |
Why?
|
Replicon | 1 | 2004 | 6 | 0.070 |
Why?
|
Salmonella enterica | 1 | 2004 | 8 | 0.060 |
Why?
|
Kanamycin Kinase | 1 | 2004 | 2 | 0.060 |
Why?
|
Alberta | 1 | 2004 | 2 | 0.060 |
Why?
|
Kanamycin | 1 | 2004 | 5 | 0.060 |
Why?
|
DNA Gyrase | 1 | 2004 | 7 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2004 | 84 | 0.060 |
Why?
|
Colony Count, Microbial | 1 | 2004 | 66 | 0.060 |
Why?
|
RNA, Bacterial | 1 | 2004 | 29 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 396 | 0.060 |
Why?
|
Bacterial Adhesion | 1 | 2004 | 36 | 0.060 |
Why?
|
Coliphages | 1 | 2004 | 8 | 0.060 |
Why?
|
Models, Molecular | 2 | 2008 | 751 | 0.060 |
Why?
|
Egypt | 1 | 2004 | 6 | 0.060 |
Why?
|
Sweden | 1 | 2004 | 12 | 0.060 |
Why?
|
Quinolines | 1 | 2004 | 60 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2004 | 154 | 0.060 |
Why?
|
Restriction Mapping | 1 | 2004 | 42 | 0.060 |
Why?
|
Cattle | 1 | 2005 | 472 | 0.060 |
Why?
|
Food Microbiology | 1 | 2004 | 34 | 0.060 |
Why?
|
Protein Binding | 2 | 2005 | 913 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2006 | 298 | 0.060 |
Why?
|
Geography | 1 | 2004 | 86 | 0.060 |
Why?
|
Canada | 1 | 2004 | 121 | 0.060 |
Why?
|
Proteus mirabilis | 1 | 2003 | 1 | 0.060 |
Why?
|
Lac Repressors | 1 | 2003 | 8 | 0.060 |
Why?
|
Binding Sites | 1 | 2005 | 597 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 968 | 0.060 |
Why?
|
Golgi Apparatus | 1 | 2003 | 25 | 0.060 |
Why?
|
Macromolecular Substances | 1 | 2003 | 86 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 484 | 0.060 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2003 | 20 | 0.060 |
Why?
|
Tetracycline | 1 | 2003 | 17 | 0.060 |
Why?
|
DNA Damage | 1 | 2005 | 341 | 0.060 |
Why?
|
Shiga Toxin | 1 | 2002 | 5 | 0.060 |
Why?
|
DNA Repair | 1 | 2004 | 181 | 0.060 |
Why?
|
Oxidation-Reduction | 2 | 2005 | 407 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 111 | 0.060 |
Why?
|
Metronidazole | 1 | 2002 | 13 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 522 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2002 | 132 | 0.050 |
Why?
|
Viral Proteins | 1 | 2003 | 172 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2003 | 226 | 0.050 |
Why?
|
Signal Transduction | 1 | 2009 | 1802 | 0.050 |
Why?
|
Electrophoresis, Capillary | 1 | 1999 | 20 | 0.050 |
Why?
|
Drug Resistance, Microbial | 1 | 1999 | 26 | 0.050 |
Why?
|
Protein Disulfide-Isomerases | 1 | 1999 | 12 | 0.050 |
Why?
|
Models, Biological | 1 | 2003 | 642 | 0.040 |
Why?
|
Time Factors | 1 | 2003 | 1681 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 555 | 0.040 |
Why?
|
Models, Statistical | 1 | 2017 | 171 | 0.040 |
Why?
|
Paraquat | 2 | 2005 | 20 | 0.030 |
Why?
|
Hydrogen Peroxide | 2 | 2005 | 181 | 0.030 |
Why?
|
Prevalence | 1 | 2017 | 1425 | 0.030 |
Why?
|
O Antigens | 1 | 2010 | 5 | 0.020 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 2010 | 6 | 0.020 |
Why?
|
Peptidyl Transferases | 1 | 2010 | 3 | 0.020 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 30 | 0.020 |
Why?
|
Glycosylation | 1 | 2010 | 92 | 0.020 |
Why?
|
Phenotype | 1 | 2010 | 650 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 32 | 0.020 |
Why?
|
Oxidants | 1 | 2005 | 43 | 0.020 |
Why?
|
Carbohydrate Sequence | 1 | 2005 | 21 | 0.020 |
Why?
|
Blotting, Western | 1 | 2008 | 834 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 52 | 0.020 |
Why?
|
Guanine | 1 | 2005 | 45 | 0.020 |
Why?
|
Gene Deletion | 1 | 2005 | 156 | 0.020 |
Why?
|
Oxygen | 1 | 2005 | 193 | 0.020 |
Why?
|
Bacterial Vaccines | 1 | 2005 | 122 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 281 | 0.020 |
Why?
|
Molecular Structure | 1 | 2005 | 467 | 0.010 |
Why?
|
Mice | 2 | 2005 | 5668 | 0.010 |
Why?
|
Gastric Acidity Determination | 1 | 2003 | 2 | 0.010 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2003 | 4 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2003 | 87 | 0.010 |
Why?
|
DNA | 1 | 2005 | 549 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2005 | 1530 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2005 | 1300 | 0.010 |
Why?
|